|
Volumn 40, Issue 8, 2002, Pages 57-59
|
Is ▼ Yasmin a "truly different" pill?
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALDOSTERONE;
ANGIOTENSIN;
ANGIOTENSIN RECEPTOR ANTAGONIST;
CYPROTERONE ACETATE;
DESOGESTREL;
DESOGESTREL PLUS ETHINYLESTRADIOL;
DIANE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DROSPIRENONE;
DROSPIRENONE PLUS ETHINYLESTRADIOL;
ESTROGEN;
ETHINYLESTRADIOL;
ETHINYLESTRADIOL PLUS LEVONORGESTREL;
ETHINYLESTRADIOL PLUS NORETHISTERONE;
GESTAGEN;
GESTODENE;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HORMONE DERIVATIVE;
KIDNEY RENIN;
LEVONORGESTREL;
NONSTEROID ANTIINFLAMMATORY AGENT;
NORETHISTERONE;
ORAL CONTRACEPTIVE AGENT;
POTASSIUM ION;
POTASSIUM SPARING DIURETIC AGENT;
PROGESTERONE;
SPIRONOLACTONE;
TRIACYLGLYCEROL;
ACNE;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DRUG CONTRAINDICATION;
DRUG COST;
DRUG EFFECT;
DRUG MARKETING;
DRUG MECHANISM;
DRUG POTENTIATION;
DRUG SAFETY;
FEMALE;
HEART INFARCTION;
HUMAN;
MAJOR CLINICAL STUDY;
MENSTRUATION DISORDER;
NAUSEA;
ORAL CONTRACEPTION;
OVULATION INHIBITION;
QUALITY OF LIFE;
SKIN MANIFESTATION;
STROKE;
THROMBOEMBOLISM;
UNITED KINGDOM;
WEIGHT GAIN;
|
EID: 0036678955
PISSN: 00126543
EISSN: None
Source Type: Journal
DOI: 10.1136/dtb.2002.40857 Document Type: Article |
Times cited : (6)
|
References (15)
|